Prof. MEHMET DOĞANAY

Publication Network

Articles 172

1. Sepsis: An Overview of Current Therapies and Future Research

Demir O., YONDEM O. Z., YÜKSEL B. E., Doganay M.

Journal of clinical practice and research , vol.47, no.2, pp.99-110, 2025 (ESCI, TRDizin)

2. Soil Sample Analysis of Bacillus anthracis Contaminated Animal Burial Sites

Sahin M., Laws T. R., Dyson H., Celebi O., DOĞANAY M., Buyuk F., et al.

Microorganisms , vol.12, no.10, 2024 (SCI-Expanded, Scopus)

3. Evaluation of Clinical Course and Outcomes of Severe Sepsis and Septic Shock in Elderly Patients

ALABAY S., KILIÇ A. U., CEVAHİR F., ALP E., DOĞANAY M.

Journal of clinical practice and research , vol.46, no.1, pp.84-91, 2024 (TRDizin)

4. Human Exposure to Naturally Occurring Bacillus anthracis in the Kars Region of Eastern Türkiye

Buyuk F., Dyson H., Laws T. R., Celebi O., DOĞANAY M., Sahin M., et al.

Microorganisms , vol.12, no.1, 2024 (SCI-Expanded, Scopus)

5. Üniversite Öğrencilerinin Covıd-19 Korkusu İle Covıd-19 Aşısına Yönelik Tutum ve Davranışlarının Belirlenmesi

Göçer S., Şimşek Küçükkelepçe D., Gölbaşı Z., Doğanay M.

GEVHER NESIBE JOURNAL OF MEDICAL AND HEALTH SCIENCES, , vol.9, no.1, pp.163-174, 2024 (Peer-Reviewed Journal)

6. Natural Disasters and Medical Counter Measurements

Göçer S., Doğanay M.

Lokman Hekim Health Sciences , vol.3, no.3, pp.234-235, 2023 (Peer-Reviewed Journal)

7. Earthquake in Türkiye: Impact on Health Services and Infection Threats

Orak Y., Orak F., Göçer S., Doğanay M.

Journal of clinical practice and research , vol.45, no.6, pp.549-557, 2023 (TRDizin) Sustainable Development

8. Severe and complicated soft tissue infections: A single-centre case series

TÜRE YÜCE Z., Unuvar G. K., Esmaoglu A., Ulu-Kilic A., Coruh A., DOĞANAY M.

Journal of Wound Care , vol.32, no.8, pp.492-499, 2023 (SCI-Expanded, Scopus)

9. Human Anthrax: Update of the Diagnosis and Treatment.

Doganay M., Dinc G., Kutmanova A., Baillie L.

Diagnostics (Basel, Switzerland) , vol.13, no.6, 2023 (SCI-Expanded, Scopus)

10. A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins

Acar M. B., Ayaz-Güner Ş., GÜNER H., DİNÇ G., ULU KILIÇ A., DOĞANAY M., et al.

Frontiers in Immunology , vol.13, 2022 (SCI-Expanded, Scopus)

11. Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection

Ascough S., Ingram R. J., Chu K. K. Y., Moor S. J., Gallagher T., Dyson H., et al.

VACCINES , vol.20, no.10(10), pp.1-17, 2022 (SCI-Expanded, Scopus) Sustainable Development

12. The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy

Alp Meşe E., Gönen Z. B., Gündoğan K., Esmaoğlu A., Kaynar L., Çetin A., et al.

EMERGENCY MEDICINE INTERNATIONAL , vol.9222379, pp.1-9, 2022 (Peer-Reviewed Journal)

13. Current infection prevention and control strategies of COVID-19 in hospitals

KALIN ÜNÜVAR G., DOĞANAY M., Alp E.

Turkish journal of medical sciences , vol.51, no.SI1, pp.3215-3220, 2021 (SCI-Expanded, Scopus, TRDizin)

14. The investigation of adrenal involvement in carbapenem resistant Acinetobacter baumannii sepsis: experimental mouse model

Eryılmaz-Eren E., DİNÇ G., KONTAŞ O., Alp E., DOĞANAY M.

Turkish journal of medical sciences , vol.51, no.6, pp.3108-3114, 2021 (SCI-Expanded, Scopus, TRDizin)

15. **Investigation of double-carbapenem efficiency in experimental sepsis of colistin-resistant Klebsiella pneumoniae.**

Kosar I., DİNÇ G., Eren E., Aykemat Y., Kilic M., Kilic H., et al.

Northern clinics of Istanbul , vol.8, no.2, pp.113-118, 2021 (Peer-Reviewed Journal) Sustainable Development

16. Human anthrax in Turkey: A ten years' experience (2009-2018).

Topluoglu S., Aktas D., Celebi B., Kara F., Doganay M., Alp E.

Tropical doctor , vol.51, no.1, pp.80-83, 2021 (SCI-Expanded, Scopus) Sustainable Development

17. Medical conditions of Omer Seyfettin (1884-1920), the father of Turkish short stories, enshrined as a mystery.

TEKİNER H., Yale S. H., Yale E. S., Doganay M.

Journal of medical biography , 2020 (SCI-Expanded, AHCI, Scopus)

18. The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model

DİNÇ G., Eren E., KONTAŞ O., DOĞANAY M.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.39, no.9, pp.1739-1744, 2020 (SCI-Expanded, Scopus)

19. Human anthrax in Kyrgyz Republic: Epidemiology and clinical features

Kutmanova A., DOĞANAY M., Zholdoshev S.

JOURNAL OF INFECTION AND PUBLIC HEALTH , vol.13, no.8, pp.1161-1165, 2020 (SCI-Expanded, Scopus) Sustainable Development

20. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes

Dumas E. K., DEMİRASLAN H., Ingram R. J., Sparks R. M., Muns E., Zamora A., et al.

PLOS ONE , vol.15, no.4, 2020 (SCI-Expanded, Scopus)

21. Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock

GÖNEN Z. B., DİNÇ G., DOĞANAY M.

ERCIYES MEDICAL JOURNAL , vol.42, no.1, pp.1-2, 2020 (ESCI, TRDizin)

22. New threat: 2019 novel Coronavirus infection and infection control perspective in Turkey

Kilic A. U., Kara F., Alp E., DOĞANAY M.

NORTHERN CLINICS OF ISTANBUL , vol.7, no.2, pp.95-98, 2020 (ESCI, TRDizin)

23. Risk prediction for candidemia in surgical intensive care unit patients

Kilic A. U., BAŞAĞA S. M., Cevahir F., Cakir O., DOĞANAY M., Alp E.

NORTHERN CLINICS OF ISTANBUL , vol.7, no.4, pp.348-353, 2020 (ESCI, TRDizin)

24. Current therapeutic strategy in osteoarticular brucellosis.

Unuvar G., Kilic A., DOĞANAY M.

Northern clinics of Istanbul , vol.6, no.4, pp.415-420, 2019 (Peer-Reviewed Journal)

25. Epidemiological features of tularaemia in Central Anatolia, Turkey

BORLU A., Benli A. R., DOĞANAY M.

Tropical Doctor , vol.49, no.4, pp.264-268, 2019 (SCI-Expanded, Scopus)

26. An Unusual Suicidal Attempt with Injection of Thinner into The Left Arm Presenting with Severe Soft Tissue Infection: A Case Report

ABEDİ A. H., KARAMAN I., Doganay M.

ERCIYES MEDICAL JOURNAL , vol.40, no.2, pp.93-94, 2018 (ESCI, Scopus, TRDizin)

27. Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats

Inci A., Doganay M., Ozdarendeli A., Düzlü Ö., Yildirim A.

TÜRKİYE PARAZİTOLOJİ DERGİSİ , vol.42, pp.39-80, 2018 (Peer-Reviewed Journal)

28. The role of nonsteroidal anti-inflammatory drugs intramuscular injection in the development and severity of deep soft tissue infection in mice

TÜRE Z., Demiraslan H., KONTAŞ O., Alp E., DOĞANAY M.

FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.32, no.2, pp.147-154, 2018 (SCI-Expanded, Scopus)

29. Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats.

İnci A., Doğanay M., Özdarendeli A., Düzlü Ö., Yıldırım A.

Turkiye parazitolojii dergisi , vol.42, pp.39-80, 2018 (Peer-Reviewed Journal)

30. Bone Marrow Transplantation and Medical Tourism at Erciyes University - A Single Center Experience

DOĞANAY M., ALP MEŞE E., ÇETİN M., TirenVerbeet N.

International Journal of Travel Medicine and Global Health , vol.6, no.1, pp.1-6, 2018 (Peer-Reviewed Journal)

31. Severe Herpes Zoster Ophtalmicus in an Immuncompromised Patient

Eren E., KAYNAR L., DOĞANAY M.

ERCIYES MEDICAL JOURNAL , vol.40, no.4, pp.240-241, 2018 (ESCI, TRDizin)

32. Multiple papular lesions in a patient with HIV and/or AIDS and coinfected with hepatitis B virus: Amyloidosis

Demiraslan H., DENİZ K., DOĞANAY M.

SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE , vol.18, no.1, 2017 (SCI-Expanded, Scopus)

33. Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?

Alhashem F., Tiren-Verbeet N. L., Alp E., DOĞANAY M.

WORLD JOURNAL OF CLINICAL CASES , vol.5, no.8, pp.324-332, 2017 (SCI-Expanded)

34. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions

Koehler S. M., Buyuk F., Celebi O., Demiraslan H., DOĞANAY M., Sahin M., et al.

BMC VETERINARY RESEARCH , vol.13, 2017 (SCI-Expanded, Scopus)

35. Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia

Demiraslan H., ATALAY M. A., EREN E., Demir K., KAYNAR L., KOÇ A. N., et al.

MEDICAL MYCOLOGY , vol.55, no.5, pp.535-540, 2017 (SCI-Expanded, Scopus)

36. The epidemiological investigation and controlof an anthrax outbreak in a village in CentralAnatolia, Turkey

DEMİRASLAN H., BORLU A., Şahin S., BÜYÜK F., Karadağ Y., DOĞANAY M., et al.

Pathogens and Global Health , vol.111, pp.206-211, 2017 (SCI-Expanded, Scopus)

37. Unexpected risks for campers and hikers: tick-borne infections

DİNÇ G., DEMİRASLAN H., DOĞANAY M.

International Journal of Travel Medicine and Global Health , vol.5, pp.5-13, 2017 (Peer-Reviewed Journal)

38. An Overwiev of ORF Virus Infection in Humans and Animals

DEMİRASLAN H., DİNÇ G., DOĞANAY M.

Recent patents on Anti-Infective drug discovery , vol.12, pp.21-30, 2017 (Scopus)

39. The epidemiological investigation and control of an anthrax outbreak in a village in Central Anatolia, Turkey

Demiraslan H., BORLU A., SAHIN S., Buyuk F., KARADAG Y., DOĞANAY M., et al.

PATHOGENS AND GLOBAL HEALTH , vol.111, no.4, pp.206-211, 2017 (SCI-Expanded, Scopus)

40. Comparison of efficacy and costof three different antimicrobial prophylaxis drugsin microsurgical transsphenoidal surgery

ULUTABANCA H., ULU KILIÇ A., ALP MEŞE E., ORHAN T., SELÇUKLU A., DOĞANAY M.

Canadian Journal of Infection Control , 2017 (Peer-Reviewed Journal)

41. Kayseri’de Yurt Dışı Kaynaklı Plasmodium falciparum Sıtma Olgu Serisi ve Literatür Özeti

MUMCU N., DEMİRASLAN H., DÜNDAR A., KUK S., YAZAR S., DOĞANAY M.

Türkiye Parazitoloji Dergisi , vol.41, 2017 (Peer-Reviewed Journal) Sustainable Development

42. Tick-Borne Diseases in Turkey: A Review Based on One Health Perspective.

Inci A., Yildirim A., Duzlu O., Doganay M., Aksoy S.

PLoS neglected tropical diseases , vol.10, 2016 (SCI-Expanded, Scopus)

43. Tick Borne Diseases in Turkey A Review Based on One HealthPerspective

İNCİ A., YILDIRIM A., DÜZLÜ Ö., DOĞANAY M., AKSOY S.

Plos Neglected Tropical Diseases , 2016 (SCI-Expanded, Scopus)

44. Ultrasonography and contrast-enhanced CT findings of tularemia in the neck

DOĞAN S., Ekinci A., Demiraslan H., KILIC A., Mavili E., ÖZTÜRK M., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , vol.22, no.5, pp.430-435, 2016 (SCI-Expanded, Scopus, TRDizin)

45. REFUGEES OF THE SYRIAN CIVIL WAR: IMPACT ON REEMERGING INFECTIONS, HEALTH SERVICES, AND BIOSECURITY IN TURKEY

DOĞANAY M., Demiraslan H.

HEALTH SECURITY , vol.14, no.4, pp.220-225, 2016 (SSCI, Scopus) Sustainable Development

46. Comparison of total, salivary and calculated free cortisol levels in patients with severe sepsis.

Elbuken G., Karaca Z. C., Tanriverdi F., Unluhizarci K., Sungur M., Doganay M., et al.

Journal of intensive care , vol.4, pp.3, 2016 (SCI-Expanded, Scopus)

47. Measles, One of the Reemerging Diseases

TÜRE YÜCE Z., DEMİRASLAN H., TOK T., DOĞANAY M.

J Microbiol Infect Dis , vol.6, no.1, pp.19-22, 2016 (Scopus) Sustainable Development

48. The prevalence of tularemia in occupational groups that have contact with animals

Buyuk F., Celebi O., Celik E., ÇELEBİ B., KILIÇ S., Saglam A. G., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.2, pp.451-456, 2016 (SCI-Expanded, Scopus, TRDizin)

49. Injectional severe soft tissue infection

Ture Z., Demiraslan H., ÇORUH A., Alp E., DOĞANAY M.

INFECTIOUS DISEASES , vol.48, no.9, pp.708-711, 2016 (SCI-Expanded, Scopus)

50. Feasibility of a new clinical severity scoring index for Crimean-Congo Hemorrhagic fever*

Kalin G., Metan G., Demiraslan H., DOĞANAY M.

JOURNAL OF CHEMOTHERAPY , vol.27, no.6, pp.353, 2015 (SCI-Expanded, Scopus)

51. Establishing molecular microbiology facilities in developing countries

AHMED S. S., Alp E., ULU-KILIC A., DOĞANAY M.

JOURNAL OF INFECTION AND PUBLIC HEALTH , vol.8, no.6, pp.513-525, 2015 (SCI-Expanded, Scopus) Sustainable Development

52. Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines

Ingram R. J., Ascough S., Reynolds C. J., Metan G., DOĞANAY M., BAİLLİE L., et al.

CELL AND BIOSCIENCE , vol.5, 2015 (SCI-Expanded, Scopus)

53. Human Anthrax as a Re-Emerging Disease

DOĞANAY M., DEMİRASLAN H.

Recent patents on anti-infective drug discovery , vol.0, 2015 (Scopus) Sustainable Development

54. Prospective investigation of the hypothalamo-pituitary-adrenal axis in patients with tularemia

Demiraslan H., Simsek Y., TANRIVERDİ F., DOĞANAY M., Kelestemur H. F.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.3, pp.558-561, 2015 (SCI-Expanded, Scopus, TRDizin)

55. Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii

Dinç G., Demiraslan H., Elmali F., Ahmed S. S., Alp E., Doğanay M.

NEW MICROBIOLOGICA , vol.38, pp.67-73, 2015 (SCI-Expanded, Scopus)

56. Cost- effectiveness analysis of appropriate duration of antibiotic prophylaxis for prevention of neurosurgical infections in a middle income country

ULU KILIÇ A., ALP MEŞE E., CEVAHİR F., TUCER B., DEMİRASLAN H., SELÇUKLU A., et al.

AMERICAN JOURNAL OF INFECTION CONTROL , vol.43, pp.44-47, 2015 (SCI-Expanded, Scopus)

57. Pet hayvanlardan insanlara bulaşan önemli bakteriyel enfeksiyonlar

DİNÇ G., DOĞANAY M., İZGÜR M.

Turk Hijyen ve Deneysel Biyoloji Dergisi , vol.72, pp.163-174, 2015 (Peer-Reviewed Journal)

58. ANTIMICROBIAL RESISTANCE PROFILE OF ESCHERICHIA COLI CAUSING BACTEREMIA IN PATIENTS IN INTENSIVE CARE UNITS

Durmaz S., KİRAZ A., PERCIN D., DOĞANAY M.

ACTA MEDICA MEDITERRANEA , vol.31, no.3, pp.633-637, 2015 (SCI-Expanded, Scopus)

59. Economic evaluation of appropriate duration of antibiotic prophylaxis for prevention of neurosurgical infections in a middle-income country

ULU-KILIC A., Alp E., Cevahir F., Tucer B., Demiraslan H., SELÇUKLU A., et al.

AMERICAN JOURNAL OF INFECTION CONTROL , vol.43, no.1, pp.44-47, 2015 (SCI-Expanded, Scopus)

60. An overview: Tularemia and travel medicine

Ulu-Kilic A., DOĞANAY M.

TRAVEL MEDICINE AND INFECTIOUS DISEASE , vol.12, no.6, pp.609-616, 2014 (SCI-Expanded, Scopus) Sustainable Development

61. Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination

Demiraslan H., Dinç G., Ahmed S. S., Elmali F., Metan G., Alp E., et al.

JOURNAL OF CHEMOTHERAPY , vol.26, pp.276-281, 2014 (SCI-Expanded, Scopus)

62. Feasibility of a new clinical severity scoring index for Crimean-Congo Hemorrhagic fever.

Kalın G., METAN G., DEMİRASLAN H., DOĞANAY M.

JOURNAL OF CHEMOTHERAPY , vol.1, pp.1, 2014 (SCI-Expanded, Scopus)

63. Incidence, risk factors and etiological agents of surgical site infections in general surgery in a developing country

ALP MEŞE E., ELMALI F., Ersoy S., KÜÇÜK K. C., DOĞANAY M.

SURGERY TODAY , vol.44, pp.685-689, 2014 (SCI-Expanded, Scopus)

64. Do We Really Need Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever?

Kalın G., Metan G., Demiraslan H., DOĞANAY M.

JOURNAL OF CHEMOTHERAPY , vol.26, no.3, pp.146-149, 2014 (SCI-Expanded, Scopus)

65. Anthrax Lethal Factor as an Immune Target in Humans and Transgenic Mice and the Impact of HLA Polymorphism on CD4(+) T Cell Immunity

Ascough S., Ingram R. J., Chu K. K., Reynolds C. J., Musson J. A., DOĞANAY M., et al.

PLOS PATHOGENS , vol.10, no.5, 2014 (SCI-Expanded, Scopus)

66. Incidence and risk factors of surgical site infection in general surgery in a developing country

Alp E., Elmali F., ERSOY S., KUCUK C., DOĞANAY M.

SURGERY TODAY , vol.44, no.4, pp.685-689, 2014 (SCI-Expanded, Scopus)

67. Tularemia outbreaks in Kayseri, Turkey: An evaluation of the effect of climate change and climate variability on tularemia outbreaks

BALCI E., Borlu A., KILIC A., Demiraslan H., OKSUZKAYA A., DOĞANAY M.

JOURNAL OF INFECTION AND PUBLIC HEALTH , vol.7, no.2, pp.125-132, 2014 (SCI-Expanded, Scopus) Sustainable Development

68. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

Kalin G., Alp E., AKİN A., Coskun R., DOĞANAY M.

INFECTION , vol.42, no.1, pp.37-42, 2014 (SCI-Expanded, Scopus)

69. Cutaneous candidiasis caused by Candida glabrata in a HIV/AIDS patient

Demiraslan H., ALABAY S., KILIC A., BORLU M., DOĞANAY M.

INTERNATIONAL JOURNAL OF STD & AIDS , vol.24, no.9, pp.753-755, 2013 (SCI-Expanded, Scopus) Sustainable Development

70. Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1

Ingram R. J., Harris A., Ascough S., Metan G., DOĞANAY M., Ballie L., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.173, no.1, pp.84-91, 2013 (SCI-Expanded, Scopus)

71. ASSESSMENT OF KNOWLEDGE OF SEXUAL TRANSMITTED DISEASES (STDS) AND A SEROPREVALENCE STUDY IN GAY MAN IN KAYSERI, TURKEY

BALCI E., DOĞANAY M., DEMIRASLAN H., GÖKAHMETOĞLU S.

SEXUALLY TRANSMITTED INFECTIONS , vol.89, 2013 (SCI-Expanded, Scopus)

72. Human Brucellosis: Importance of Brucellosis.

Doganay M.

Recent patents on anti-infective drug discovery , vol.8, no.1, pp.2-3, 2013 (Scopus)

73. Brucella as a potential agent of bioterrorism.

Doganay G. D., Doganay M.

Recent patents on anti-infective drug discovery , vol.8, no.1, pp.27-33, 2013 (Scopus)

74. Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis

Dinç G., Demiraslan H., Elmali F., Ahmed S. S., Metan G., Alp E., et al.

CHEMOTHERAPY , vol.59, pp.325-329, 2013 (SCI-Expanded, Scopus)

75. Clinical Approach to Skin Eruption and Measles: A Mini Review

Batırel A., DOĞANAY M.

Journal of General Practice , vol.1, no.3, pp.1-4, 2013 (Peer-Reviewed Journal) Sustainable Development

76. Tularemia: A re-emerging disease

KILIC A., DOĞANAY M.

ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI , vol.60, no.4, pp.275-280, 2013 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

77. Vectors and Vector-Borne Diseases in Turkey

İNCİ A., Yazar S., TUNÇBİLEK A. Ş., CANHİLAL R., DOĞANAY M., Aydın L., et al.

ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI , vol.60, no.4, pp.281-296, 2013 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

78. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?

Kalin G., Alp E., Coskun R., Demiraslan H., GÜNDOĞAN K., DOĞANAY M.

JOURNAL OF INFECTION AND CHEMOTHERAPY , vol.18, no.6, pp.872-877, 2012 (SCI-Expanded, Scopus)

79. Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity?

TANRIVERDİ F., DE BELLIS A., TEKSAHIN H., ALP E., BIZZARRO A., SINISI A. A., et al.

PITUITARY , vol.15, no.4, pp.579-588, 2012 (SCI-Expanded, Scopus)

80. Molecular epidemiology of the Bacillus anthracis isolates collected throughout Turkey from 1983 to 2011

Durmaz R., DOĞANAY M., Sahin M., Percin D., Karahocagil M. K., Kayabas U., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.31, no.10, pp.2783-2790, 2012 (SCI-Expanded, Scopus)

81. A Rare Clinical Presentation and Outcome of Cutaneous Anthrax: Toxemic Shock: Case Report

DOĞANAY M., Metan G.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.32, no.3, pp.841-845, 2012 (SCI-Expanded, Scopus)

82. Comment on "Frequency of Epitope-Specific Naive CD4(+) T Cells Correlates with Immunodominance in the Human Memory Repertoire"

ASCOUGH S., INGRAM R. J., Metan G., MAILLERE B., DOĞANAY M., ÖZKUL Y., et al.

JOURNAL OF IMMUNOLOGY , vol.188, no.11, pp.5205-5206, 2012 (SCI-Expanded, Scopus)

83. Risk Factors for Nosocomial Infection and Mortality in Burn Patients: 10 Years of Experience at a University Hospital

Alp E., ÇORUH A., GÜNAY G. K., Yontar Y., DOĞANAY M.

JOURNAL OF BURN CARE & RESEARCH , vol.33, no.3, pp.379-385, 2012 (SCI-Expanded, Scopus) Sustainable Development

84. Prevaccination screening of health-care workers for immunity to measles,rubella, mumps, and varicella in a developing country

ALP MEŞE E., Cevahir F., GÖKAHMETOĞLU S., DEMİRASLAN H., DOĞANAY M.

JOURNAL OF INFECTION AND PUBLIC HEALTH , vol.5, pp.127-132, 2012 (Scopus)

85. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?

Alp E., Cevahir F., Gökahmetoglu S., Demiraslan H., Doganay M.

Journal of infection and public health , vol.5, no.2, pp.127-32, 2012 (SCI-Expanded, Scopus) Sustainable Development

86. Naturally Occurring Cutaneous Anthrax: Antibiotic Treatment and Outcome

Kayabas U., Karahocagil M. K., ÖZKURT Z., Metan G., PARLAK E., BAYINDIR Y., et al.

CHEMOTHERAPY , vol.58, no.1, pp.34-43, 2012 (SCI-Expanded, Scopus)

87. Nosocomial candidemia: A threat beyond nosocomial bacterial infections in intensive care units

MESE E. A., Agkus C., Coskun R., Metan G., KOC A. N., SUNGUR M., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.41, no.6, pp.1115-1118, 2011 (SCI-Expanded, Scopus, TRDizin)

88. Güneydoğu Anadolu’da İkinci Basamak Bir Hastanede Brusellozlu Hastaların Klinik/Laboratuvar Bulguları ve Tedavi Özelliklerinin Değerlendirilmesi

DEMİRASLAN H., Aksöz S., METAN G., DOĞANAY M.

FLORA İNFEKSİYON HASTALIKLARI VE KLİNİK MİKROBİYOLOJİ DERGİSİ , vol.14, no.4, pp.152-159, 2011 (TRDizin) Sustainable Development

89. Changing pattern of antibiotic susceptibility in intensive care units: Ten years experience of a university hospital

Alp E., KIRAN B., ALTUN D., Kalin G., Coskun R., SUNGUR M., et al.

ANAEROBE , vol.17, no.6, pp.422-425, 2011 (SCI-Expanded, Scopus)

90. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin

Kurnaz F., Metan G., Coskun R., KAYNAR L., ESER B., DOĞANAY M.

TROPICAL DOCTOR , vol.41, no.3, pp.181-182, 2011 (SCI-Expanded, Scopus)

91. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax

Brenneman K. E., DOĞANAY M., Akmal A., Goldman S., Galloway D. R., Mateczun A. J., et al.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY , vol.62, no.2, pp.164-172, 2011 (SCI-Expanded, Scopus)

92. Importance of structured training programs and good role models in hand hygiene in developing countries.

Alp E., Ozturk A., Guven M., Celik I., Doganay M., Voss A.

Journal of infection and public health , vol.4, no.2, pp.80-90, 2011 (SCI-Expanded, Scopus) Sustainable Development

93. Are gram negative bacilli a threat for prosthetic joint replacements? Experience of a university hospital

MESE E. A., HALICI M., KIRAN E. B., ARGÜN M., DOĞANAY M.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.41, no.1, pp.173-175, 2011 (SCI-Expanded, Scopus, TRDizin)

94. Hospitalized pandemic influenza A (H1N1) patients in a university hospital

Metan G., Bozkurt I., Agkus C., Coskun R., Alp E., SUNGUR M., et al.

CENTRAL EUROPEAN JOURNAL OF MEDICINE , vol.6, no.1, pp.83-88, 2011 (SCI-Expanded, Scopus)

95. Epidemiological and Clinical Characteristics of HIV/AIDS Patients Followed-up in Cappadocia Region: 18 Years Experience

Alp E., Bozkurt I., DOĞANAY M.

MIKROBIYOLOJI BULTENI , vol.45, no.1, pp.125-136, 2011 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

96. KAYSERİDE TULAREMİ VE HEKİMLERİN TULAREMİ KONUSUNDAKİ BİLGİ VE DAVRANIŞLARININ DEĞERLENDİRİLMESİ

BALCI E., BORLU A., OKSUZKAYA A., DOĞANAY M.

STED , vol.20, pp.231-239, 2011 (Peer-Reviewed Journal)

97. Investigation and analysis of a human orf outbreak among people living on the same farm

Bayindir Y., Bayraktar M., KARADAĞ N., Ozcan H., Kayabas U., OTLU B., et al.

NEW MICROBIOLOGICA , vol.34, no.1, pp.37-43, 2011 (SCI-Expanded, Scopus) Sustainable Development

98. Infection control practice in countries with limited resources

Alp E., Leblebicioglu H., DOĞANAY M., VOSS A.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS , vol.10, 2011 (SCI-Expanded, Scopus)

99. Acute Postinfectious Glomerulonephritis with Native Aorta Valve Endocarditis and Myopericarditis Due to Brucellosis

KOÇYİĞİT I., Celik A., TOKGÖZ B., Ozdogru I., AKGÜN H., DOĞANAY M., et al.

RENAL FAILURE , vol.33, no.3, pp.367-370, 2011 (SCI-Expanded, Scopus) Sustainable Development

100. A review of cutaneous anthrax and its outcome

DOĞANAY M., Metan G., Alp E.

Journal of Infection and Public Health , vol.3, no.3, pp.98-105, 2010 (SCI-Expanded, Scopus)

101. An Epitope of Bacillus anthracis Protective Antigen That Is Cryptic in Rabbits May Be Immunodominant in Humans

Ingram R. J., Chu K. K., Metan G., Maillere B., DOĞANAY M., ÖZKUL Y., et al.

INFECTION AND IMMUNITY , vol.78, no.5, pp.2353, 2010 (SCI-Expanded, Scopus)

102. Natural Exposure to Cutaneous Anthrax Gives Long-Lasting T Cell Immunity Encompassing Infection-Specific Epitopes

INGRAM R. J., METAN G., MAILLERE B., DOĞANAY M., ÖZKUL Y., KIM L. U., et al.

JOURNAL OF IMMUNOLOGY , vol.184, no.7, pp.3814-3821, 2010 (SCI-Expanded, Scopus)

103. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus and clonal spread of the isolates in a medical intensive care unit

Alp E., Yerer M., ESEL D., METAN G., DOĞANAY M.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.39, no.6, pp.941-951, 2009 (SCI-Expanded, Scopus, TRDizin)

104. Neurobrucellosis: an evaluation of a rare presentation of brucellosis from a tertiary care centre in Central Anatolia, Turkey

Demiraslan H., Metan G., MESE E. A., YILDIZ O., AYGEN B., SUMERKAN B., et al.

TROPICAL DOCTOR , vol.39, no.4, pp.233-235, 2009 (SCI-Expanded, Scopus)

105. The risk factors and spread of multidrug-resistant Acinetobacter baumannii in intubated patients in a medical intensive care unit

Alp E., Yerer M., Kocagoz S., METAN G., ESEL D., Guerol Y., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.39, no.5, pp.761-769, 2009 (SCI-Expanded, Scopus, TRDizin)

106. ANTHRAX MENINGOENCEPHALITIS: A CASE REPORT AND REVIEW OF TURKISH LITERATURE

METAN G., Uysal B., Coskun R., PERCIN D., DOĞANAY M.

MIKROBIYOLOJI BULTENI , vol.43, no.4, pp.671-676, 2009 (SCI-Expanded, Scopus, TRDizin)

107. MRSA genotypes in Turkey: Persistence over 10 years of a single clone of ST239

Alp E., KLAASSEN C. H. W., DOĞANAY M., ALTOPARLAK Ü., Aydin K., Engin A., et al.

JOURNAL OF INFECTION , vol.58, no.6, pp.433-438, 2009 (SCI-Expanded, Scopus)

108. Human Anthrax in Turkey from 1990 to 2007

DOĞANAY M., Metan G.

VECTOR-BORNE AND ZOONOTIC DISEASES , vol.9, no.2, pp.131-139, 2009 (SCI-Expanded, Scopus) Sustainable Development

109. The Antimicrobial Susceptibility of Bacillus anthracis Isolated from Human Cases: A Review of the Turkish Literature

METAN G., DOĞANAY M.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.1, pp.229-235, 2009 (SCI-Expanded, Scopus) Sustainable Development

110. Current therapeutic strategy in spinal brucellosis

Alp E., DOĞANAY M.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.12, no.6, pp.573-577, 2008 (SCI-Expanded, Scopus)

111. Investigation of pituitary functions in patients with acute meningitis: A pilot study

TANRIVERDİ F., ALP E., DEMIRASLAN H., Dokmetas H. S., ÜNLÜHİZARCI K., DOĞANAY M., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.31, no.6, pp.489-491, 2008 (SCI-Expanded, Scopus) Sustainable Development

112. Sepsis and meningitis due to Listeria monocytogenes

Yildiz O., Aygen B., ESEL D., Kayabas U., Alp E., SUMERKAN B., et al.

YONSEI MEDICAL JOURNAL , vol.48, no.3, pp.433-439, 2007 (SCI-Expanded, Scopus)

113. Methicillin resistant staphylococcus aureus (MRSA) colonization on admission to an intensive care unit

Yerer M., Metan G., Alp E., Esel D., GÜVEN M., DOĞANAY M.

ERCIYES MEDICAL JOURNAL , vol.29, no.2, pp.110-114, 2007 (ESCI, Scopus, TRDizin)

114. Disseminated nocardiosis due to unusual species: Two case reports

Alp E., YILDIZ O., AYGEN B., Sumerkan B., Sari I., Koc K., et al.

Scandinavian Journal of Infectious Diseases , vol.38, no.6-7, pp.545-548, 2006 (SCI-Expanded, Scopus) Sustainable Development

115. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital

ALP E., ESEL D., YILDIZ O., VOSS A., MELCHERS W., Doganay M.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.38, no.5, pp.335-340, 2006 (SCI-Expanded, Scopus) Sustainable Development

116. Actinomycoses and Nocardia pulmonary infections

Yildiz O., Doganay M.

CURRENT OPINION IN PULMONARY MEDICINE , vol.12, no.3, pp.228-234, 2006 (SCI-Expanded, Scopus) Sustainable Development

117. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]

ALP E., KOC R. K., DURAK A., YILDIZ O., AYGEN B., SUMERKAN B., et al.

BMC INFECTIOUS DISEASES , vol.6, 2006 (SCI-Expanded, Scopus)

118. Disseminated nocardiosis due to unusual species:two case report

ALP MEŞE E., YILDIZ O., AYGEN B., SÜMERKAN A. B., SARI H. I., KOÇ R. K., et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.38, pp.545-548, 2006 (SCI-Expanded)

119. Cutaneous lupoid leishmaniasis: A case report

FERAHBAS A., MISTIK S., UTAS S., YAMAN O., CANOZ O., Doganay M., et al.

CUTIS , vol.77, no.1, pp.25-28, 2006 (SCI-Expanded, Scopus)

120. Gunshot wounds and late infection

YILDIZ O., Alp E., Şimşek S., SELÇUKLU A., Doǧanay M.

Turkish Journal of Medical Sciences , vol.35, no.4, pp.269-272, 2005 (SCI-Expanded, Scopus, TRDizin)

121. Nocardiosis in a teaching hospital in the Central Anatolia region of Turkey: treatment and outcome

YILDIZ O., ALP E., TOKGOZ B., TUCER B., AYGEN B., SUMERKAN B., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.11, no.6, pp.495-499, 2005 (SCI-Expanded, Scopus)

122. Investigation of the hypothalamo-pituitary-adrenal axis and changes in the size of adrenal glands in acute brucellosis

YILDIZ O., GOKCE C., ALP E., DURAK A., AYGEN B., KELESTIMUR F., et al.

ENDOCRINE JOURNAL , vol.52, no.2, pp.183-188, 2005 (SCI-Expanded, Scopus)

123. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis

ALP E., GOZUKUCUK S., CANOZ O., KIRMACI B., Doganay M.

BMC INFECTIOUS DISEASES , vol.4, 2004 (SCI-Expanded, Scopus)

124. Bloodstream infections caused by Staphylococcus aureus in a university hospital in Turkey: clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus

AYGEN B., YORUK A., YYLDYZ O., ALP E., KOCAGOZ S., SUMERKAN B., et al.

CLINICAL MICROBIOLOGY AND INFECTION , vol.10, no.4, pp.309-314, 2004 (SCI-Expanded, Scopus)

125. Yoğun bakım ünitelerimizde nozokomiyal pnömoni insidansı, etkenleri ve antibiyotik direnci

Alp E., Güven M., YILDIZ O., SOYLU S., Sungur M., AYGEN B., et al.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , vol.9, no.2, pp.125-131, 2004 (TRDizin)

126. Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome

ESEL D., Doganay M., ALP E., SUMERKAN B.

CLINICAL MICROBIOLOGY AND INFECTION , vol.9, no.10, pp.1038-1044, 2003 (SCI-Expanded, Scopus)

127. Prospective evaluation of blood cultures in a Turkish University Hospital:microbiology, epidemiology and clinical outcome

PERÇİN RENDERS D., DOĞANAY M., ALP MEŞE E., SÜMERKAN A. B.

CLINICAL MICROBIOLOGY AND INFECTION , vol.9, pp.1038-1044, 2003 (SCI-Expanded, Scopus)

128. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey

ESEL D., Doganay M., SUMERKAN B.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.22, no.1, pp.70-72, 2003 (SCI-Expanded, Scopus)

129. Listeriosis: clinical presentation

Doganay M.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY , vol.35, no.3, pp.173-175, 2003 (SCI-Expanded)

130. Human brucellosis: An overview

DOĞANAY M., AYGEN B.

International Journal of Infectious Diseases , vol.7, no.3, pp.173-182, 2003 (SCI-Expanded, Scopus) Sustainable Development

131. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients

AYGEN B., Doganay M., SUMERKAN B., YILDIZ O., KAYABAS U.

MEDECINE ET MALADIES INFECTIEUSES , vol.32, no.9, pp.485-493, 2002 (SCI-Expanded, Scopus)

132. Polymicrobial ventriculitis and evaluation of an outbreak in a surgical intensive care unit due to inadequate sterilization

ESEL D., Doganay M., BOZDEMIR N., YILDIZ O., TEZCANER T., SUMERKAN B., et al.

JOURNAL OF HOSPITAL INFECTION , vol.50, no.3, pp.170-174, 2002 (SCI-Expanded, Scopus)

133. Surveillance of antimicrobial resistance in Gram-negative isolates from intensive care units in Turkey: Analysis of data from the last 5 years

Leblebicioglu H., Gunaydin M., Esen S., Tuncer I., Findik D., Ural O., et al.

Journal of Chemotherapy , vol.14, no.2, pp.140-146, 2002 (SCI-Expanded, Scopus)

134. Surgical site infection due to corynebacterium jeikeium: A case report Corynebacterium jei̇kei̇um'a (c. Jei̇kei̇um) baǧli cerrahi̇ alan i̇nfeksi̇yonu: Bi̇r olgu sunusu

YILDIZ O., AYGEN B., Doǧanay M., Sümerkan B., Kahraman C.

Erciyes Tip Dergisi , vol.24, no.1, pp.48-51, 2002 (SCI-Expanded, Scopus, TRDizin)

135. Brucellosis due to blood transfusion

Doganay M., AYGEN B., ESEL D.

JOURNAL OF HOSPITAL INFECTION , vol.49, no.2, pp.151-152, 2001 (SCI-Expanded, Scopus)

136. Anthrax meningitis: Case report

Yorgancigil B., Demirci M., Unlu M., Sevük E., DOĞANAY M.

International Journal of Infectious Diseases , vol.5, no.4, pp.220-221, 2001 (SCI-Expanded, Scopus)

137. A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey

GUNSEREN F., MAMIKOGLU L., OZTURK S., YUCESOY M., BIBEROGLU K., YULUG N., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.43, no.3, pp.373-378, 1999 (SCI-Expanded, Scopus)

138. Prostatitis and hepatitis due to Brucella melitensis: a case report

AYGEN B., SUMERKAN B., Doganay M., SEHMEN E.

JOURNAL OF INFECTION , vol.36, no.1, pp.111-112, 1998 (SCI-Expanded, Scopus) Sustainable Development

139. Diagnosis: cutaneous anthrax.

Doğanay M., Aygen B.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , vol.25, no.3, 1997 (SCI-Expanded, Scopus)

140. Photo quiz - Cutaneous anthrax

Doganay M., AYGEN B.

CLINICAL INFECTIOUS DISEASES , vol.25, no.3, pp.607-608, 1997 (SCI-Expanded, Scopus)

141. Adrenal functions in patients with sepsis

AYGEN B., INAN M., Doganay M., KELESTIMUR F.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.105, no.3, pp.182-186, 1997 (SCI-Expanded, Scopus)

142. Treatment of neurobrucellosis with a combination of ceftriaxone, rifampicin and doxycycline (a study on ten cases)

AYGEN B., SUMERKAN B., MIRZA M., Doganay M., ARMAN F.

MEDECINE ET MALADIES INFECTIEUSES , vol.26, no.12, pp.1199-1201, 1996 (SCI-Expanded, Scopus)

143. Klinik örneklerden izole edilen beta-hemoliz yapmayan Gram-pozitif, katalaz-negatif koklar

AYDIN N., KOÇ A. N., SÜMERKAN A. B., DOĞANAY M.

İnfeksiyon Dergisi , vol.10, no.1, pp.55-57, 1996 (TRDizin)

144. Klinik örneklerden izole edilen Enterococcus faecalis ve Enterecoccus faecium suşlarının antibiyotik duyarlılıkları

AYDIN N., KOÇ A. N., SÜMERKAN A. B., FAZLI Ş. A., DOĞANAY M.

Türk Hijyen ve Deneysel Biyoloji Dergisi 53 (1):1-6, 1996. , vol.53, no.1, pp.1-6, 1996 (Peer-Reviewed Journal)

145. ACUTE-RENAL-FAILURE ASSOCIATED WITH RHINOSINUSO-ORBITAL MUCORMYCOSIS INFECTION IN A PATIENT WITH DIABETIC NEPHROPATHY

UTAS C., UNLUHIZARCI K., OKTEN T., UNLU Y., DOGANAY M., KELESTIMUR F.

NEPHRON , vol.71, no.2, pp.235, 1995 (SCI-Expanded, Scopus) Sustainable Development

146. TREATMENT OF TUBERCULOUS MENINGITIS IN TURKEY

DOGANAY M., CALANGU S., TURGUT H., BAKIR M., AYGEN B.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.27, no.2, pp.135-138, 1995 (SCI-Expanded, Scopus)

147. Penicillin resistance in Streptococcus pneumoniae in Turkey Résistance à la pénicilline G de Streptococcus pneumoniae en Turquie

Sümerkan B., AYGEN B., DOĞANAY M.

Medecine et Maladies Infectieuses , vol.25, no.12, pp.1219-1220, 1995 (SCI-Expanded, Scopus)

148. Kala-azar: Report of three cases

GÜVEN K., ÜNAL A., Kandemir O., AYGEN B., DOĞANAY M.

Mikrobiyoloji Bulteni , vol.28, no.4, pp.378-384, 1994 (SCI-Expanded, Scopus)

149. Pneumocystis carinii pneumonia: Report of three cases

AYGEN B., Sumerkan B., Inan M., Kandemir O., DOĞANAY M., Ozesmi M., et al.

Mikrobiyoloji Bulteni , vol.28, no.4, pp.385-391, 1994 (SCI-Expanded, Scopus) Sustainable Development

150. Temporal artery inflammation as a complication of anthrax.

Doganay M., Aygen B., Inan M., Kandemir O., Turnbull P.

The Journal of infection , vol.28, no.3, pp.311-4, 1994 (SCI-Expanded, Scopus)

151. POSTOPERATIVE ENDOPHTHALMITIS CAUSED BY AN ENTEROBACTER SPECIES

MIRZA G., KARAKUCUK S., DOGANAY M., CAGLAYANGIL A.

JOURNAL OF HOSPITAL INFECTION , vol.26, no.3, pp.167-172, 1994 (SCI-Expanded, Scopus)

152. Evaluation of antimicrobial susceptibility of clinical isolates of Salmonella

Sumerkan B., Inan M., Caglayangil A., AYGEN B., DOĞANAY M.

Mikrobiyoloji Bulteni , vol.28, no.1, pp.21-26, 1994 (SCI-Expanded, Scopus)

153. Brucella peritonitis in a cirrhotic patient with ascites.

Doganay M., Aygen B., Inan M., Ozbakir O.

The European journal of medicine , vol.2, no.7, pp.441-2, 1993 (Peer-Reviewed Journal)

154. Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups Degişik gruplarda HBsAg, anti-HCV ve anti-HDV pozitifliginin karşilaştirilmasi.

DOĞANAY M., Patiroglu T., Utaş C., ÖZBAKIR Ö., ÜNAL A., Utaş S., et al.

Mikrobiyoloji bülteni , vol.27, no.2, pp.107-112, 1993 (SCI-Expanded, Scopus) Sustainable Development

155. Antimicrobial susceptibility of clinical isolates of Brucella melitensis

Sumerkan B., DOĞANAY M., Bakiskan V., Fazli S., AYGEN B.

Doga - Turkish Journal of Medical Sciences , vol.18, no.1, pp.17-22, 1993 (Scopus)

156. SEROLOGY AND ANTHRAX IN HUMANS, LIVESTOCK AND ETOSHA-NATIONAL-PARK WILDLIFE

TURNBULL P., DOGANAY M., LINDEQUE P., AYGEN B., MCLAUGHLIN J.

EPIDEMIOLOGY AND INFECTION , vol.108, no.2, pp.299-313, 1992 (SCI-Expanded, Scopus)

157. USE OF CIPROFLOXACIN IN THE TREATMENT OF BRUCELLOSIS

DOGANAY M., AYGEN B.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.11, no.1, pp.74-75, 1992 (SCI-Expanded, Scopus)

158. [The histopathological effects of different treatments on lung tissue of mice pretreated with cyclophosphamide and steroids in experimental E. coli sepsis].

Düzcan E., Bakir M., Dökmetaş I., Doğanay M., Güneş H.

Mikrobiyoloji bulteni , vol.25, no.4, pp.349-59, 1991 (SCI-Expanded, Scopus)

159. ANTIMICROBIAL SUSCEPTIBILITY OF BACILLUS-ANTHRACIS

DOGANAY M., AYDIN N.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.23, no.3, pp.333-335, 1991 (SCI-Expanded, Scopus)

160. [Antibiotic and specific immunoglobulin G in the treatment of E. coli sepsis in mice previously given steroids].

Bakir M., Doğanay M., Dökmetaş I.

Mikrobiyoloji bulteni , vol.24, no.4, pp.336-43, 1990 (SCI-Expanded, Scopus)

161. [IgG therapy of experimental E. coli sepsis in neutropenic mice].

Dökmetaş I., Doğanay M., Bakir M.

Mikrobiyoloji bulteni , vol.24, no.3, pp.205-13, 1990 (SCI-Expanded, Scopus)

162. Asymptomatic bacteriuria in patients with diabetes mellitus Diabetes mellitus'lu hastalarda asemptomatik bakteriüri.

Keleştimur F., ÜNAL A., Paşaoglu H., Başar E., KILIÇ H., DOĞANAY M.

Mikrobiyoloji bülteni , vol.24, no.2, pp.126-132, 1990 (SCI-Expanded, Scopus) Sustainable Development

163. TREATMENT OF TUBERCULOUS MENINGITIS IN ADULTS WITH A COMBINATION OF ISONIAZID, RIFAMPICIN AND STREPTOMYCIN - A PROSPECTIVE-STUDY

DOGANAY M., BAKIR M., DOKMETAS İ.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.21, no.1, pp.81-85, 1989 (SCI-Expanded, Scopus)

164. A case of cutaneous anthrax with toxaemic shock.

Doğanay M., Bakir M., Dökmetaş I.

The British journal of dermatology , vol.117, no.5, pp.659-62, 1987 (SCI-Expanded, Scopus)

165. Primary throat anthrax: A report of six cases

DOĞANAY M., Almaç A., Hanagasi R.

Scandinavian Journal of Infectious Diseases , vol.18, no.5, pp.415-419, 1986 (SCI-Expanded, Scopus) Sustainable Development

166. [Food poisoning caused by Bacillus cereus].

Doğanay M., Bakici M. Z.

Mikrobiyoloji bulteni , vol.19, no.4, pp.235-7, 1985 (SCI-Expanded, Scopus)

167. [Evaluation of penicillin alone and penicillin combined with anti-anthrax serum in experimental anthrax in mice].

Doğanay M., Hanağasi R., Zora A.

Mikrobiyoloji bulteni , vol.19, no.2, pp.57-64, 1985 (SCI-Expanded, Scopus)

168. Review of recent advances in interferon and interferon therapy

DOĞANAY M.

Mikrobiyoloji Bulteni , vol.17, no.1, pp.69-73, 1983 (SCI-Expanded, Scopus)

169. [A review of 35 anthrax cases].

Doğanay M., Kökkaya A., Hah M. M.

Mikrobiyoloji bulteni , vol.17, no.1, pp.1-10, 1983 (SCI-Expanded, Scopus)

170. [Food poisoning caused by S. san-diego (author's transl)].

Doğanay M., Aksu S. Z., Aksoycan N., Durusu Z., Meço O., Gültan K.

Mikrobiyoloji bulteni , vol.13, no.4, pp.386-7, 1979 (SCI-Expanded, Scopus, TRDizin)

171. [A case of meningitis due to Acinetobacter calcoaceticus].

Cin S., Doğanay M., Doğru U., Demirağ B.

Mikrobiyoloji bulteni , vol.13, no.1, pp.1-7, 1979 (SCI-Expanded, Scopus, TRDizin)

172. [Pseudomonas-like bacteria (group Ve biotype 1) isolated from a subdiaphragmatic abscess (author's transl)].

Doğanay M., Ozsan K., Saygun N.

Mikrobiyoloji bulteni , vol.11, no.4, pp.559-61, 1977 (SCI-Expanded, Scopus, TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 53

1. IMMUNOPROTEOMIC ANALYSIS OF ACINETOBACTER BAUMANNII SURFACE AND SECRETED PROTEINS

Murat A., Ayaz-Guner S., Acar M. B., Mert Gökduman E., Dinç G., Ulu Kılıç A., et al.

7th International Congress of the Molecular Biology Association of Turkey, İstanbul, Turkey, 27 - 29 September 2019, pp.192, (Summary Text)

2. Comparing immunogenicity of non‐living anthrax vaccine candidates in combination with simultaneous antibiotic treatment in goats and using passive mouse protection model

Henriette v. H., Okechukwu N., Koehler S., BÜYÜK F., ÇELEBİ Ö., OTLU S., et al.

The Biology of Anthrax International Conference, 3 - 06 September 2019, (Full Text) Sustainable Development

3. Human Anthrax in Turkey: A Ten Years Experience (2009-2018)

TOPLUOĞLU S., AKTAŞ D., ÇELEBİ B., KÖŞKER H. İ., DİNÇ G., DOĞANAY M., et al.

The Biology of Anthrax International Conference, Bari, Italy, 3 - 06 September 2019, (Summary Text)

4. Nötropenik farelerde karbapeneme dirençli Klebsiella pneumoniae sepsis modelinde mezenkimal kök hücre tedavisinin etkinliği

DİNÇ G., EREN E., KONTAŞ O., DOĞANAY M.

3. Kok Hucre ve Hucresel Tedaviler Kongresi, 12 - 14 April 2019, (Full Text)

5. Epidemological features of tularemia in Kayseri

BORLU A., DOĞANAY M., BENLİ A. R.

16th Medical Biodefense Conference, 28 - 31 October 2018, (Summary Text)

6. Human anthrax in Kyrgyz Republic: Epidemiologyand clinical features

DOĞANAY M.

16th Medical Biodefense Conference, 28 - 31 October 2018, (Summary Text)

7. AN INVESTIGATION OF PROTECTIVE IMMUNOGENIC PROTEINS OF ACINETOBACTER BAUMANNII WITH IMMUNOPROTEOMIC ANALYSIS

DİNÇ G., ULU KILIÇ A., mert gökduman e., acar m. b., murat a., ömerli f., et al.

16th Medical Biodefence Conferance, 28 - 31 October 2018, pp.30, (Summary Text)

8. Infection Control In ICU

DOĞANAY M.

12th International Clinical Microbiology Congress, Kerman, Iran, 16 - 18 October 2018, vol.1, pp.1-208, (Summary Text)

9. Soft Tissue Infection

DOĞANAY M.

12th International Clinical Microbiology Congress, Kerman, Iran, 16 - 18 October 2018, (Summary Text)

10. Biyolojik Terör: Dün, Bugün, Yarın!

DOĞANAY M.

Uluslararası KBRN Kongresi, Ankara, Turkey, 5 - 07 December 2017, (Summary Text) Sustainable Development

11. Investigation of the pituitary functions long-term after the acute CNS infections

ÇETİNKAYA G., ULU KILIÇ A., ÖZDAMAR KARACA Z. C., DOĞANAY M., TÜRE Z., ÜNLÜHİZARCI K., et al.

196TH ECE, 20 - 23 May 2017, (Summary Text)

12. MÜLTECİLER GÖÇLER AFETLER VE YENİ ZOONOZLAR

DOĞANAY M.

Güncel Zoonozlar, Kars, Turkey, 16 December 2016 Sustainable Development

13. Gender Differences in the Immune Responses to Anthrax Following Natural Exposure in a Turkish Cohort

Ingram R., Chitadze N., Trapaidze N., DOĞANAY M., PARLAK E., PARLAK M., et al.

The Biology of Anthrax Conference 2016, Tama, Japan, 12 - 15 November 2016

14. SEPSIS Treatment of Multidrug Resistant Gram Negative Bacterial Infections

DOĞANAY M.

10th International Congress of Clinical Microbiology. Sanandaj, Iran, 27-29 September, 2016, Sanandaj, Iran, 27 September - 01 October 2016

15. Antibiotic susceptibility of Bacillus anthracis and treatment

DOĞANAY M.

10th International Congress of Clinical Microbiology. Sanandaj, Iran, 27-29 September, 2016., Sanandaj, Iran, 27 September - 01 October 2016

16. Refugees of the Syrian Civil War Impact on Health Service and Re Emerging Infections in Turkey

DOĞANAY M.

CSCM – World Congress on CBRNe Applied Science & Consequence Management,Tbilisi, Tiflis, Georgia, 30 May - 02 June 2016 Sustainable Development

17. Diyabet modelinde karbapenem dirençli Klebsiella pneumoniae ile yumusak doku enfeksiyonu ve tedavisi

Dinç G., Demiraslan H., Ahmed S. S., Alp E., Kılıç H., Keleştemur F., et al.

6. Turkiye EKMUD Kongresi, Antalya, Turkey, 11 - 15 May 2016, vol.1, no.1, pp.70-0, (Full Text) Sustainable Development

18. An Anthrax Outbreak in a Village in Central Anantolia and Infection Control Studies

DOĞANAY M., DEMİRASLAN H., BORLU A., Şahin S., Büyük F., Karadağ Y., et al.

15th Medical Biodefense Conference, Munich, 26-29 April, 2016, Munich, Germany, 26 - 29 April 2016

19. The Regional Differences of the Human Immunological Response to Anthrax Infection

Chitadze N., DOĞANAY M., PARLAK E., KAYABAŞ Ü., PARLAK M., SÜNNETÇİOĞLU M., et al.

15th Medical Biodefense Conference, Munich, 26-29 April, 2016, Munich, Germany, 26 - 29 April 2016

20. The Impact of Environmental Contamination with Bacillus anthracis Spores on Human Health

BÜYÜK F., ÇELEBİ Ö., Linley E., Cooper C., DOĞANAY M., ŞAHİN M., et al.

15th Medical Biodefense Conference, Munich, 26-29 April, 2016., Munich, Germany, 26 - 29 April 2016 Sustainable Development

21. An Anthrax Outbreak in a Village in Central Anatol Control Studies

DOĞANAY M., DEMİRASLAN H., BORLU A., ŞAHİN S., BÜYÜK F., KARADAĞ Y., et al.

15 th Medical Biodefence Conference, Munich, 26 - 29 April 2016, (Summary Text)

22. An anthrax Outbreak in a village in Central Anatolia and Infection Control Studies

DOĞANAY M., DEMİRASLAN H., BORLU A., Şahin S., Büyük F., Şahin M., et al.

15th Medical Biodefense Conference, Münih, Germany, 26 - 29 April 2016, pp.18, (Summary Text)

23. efficacy and cost of three different antimicrobial prophylaxis drugs in microsurgical transphenoidal surgery

ULUTABANCA H., ULU KILIÇ A., ALP MEŞE E., orhan t., SELÇUKLU A., DOĞANAY M.

26.th ESCMİD 2016 (EV0869), 9 - 12 April 2016

24. The role of intramuscular injection of nonsteroidal anti-inflammatory drug (NSAID) in development and severity of deep soft tissue infections in mice

TÜRE YÜCE Z., DEMİRASLAN H., KONTAŞ O., ALP MEŞE E., DOĞANAY M.

European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Netherlands, 9 - 12 April 2016, pp.193, (Full Text)

25. efficacy and cost of three different ant microbial prophylaxis drugs in microsurgical transsphenoideal surgery a preliminery report

ULUTABANCA H., ULU KILIÇ A., ALP MEŞE E., SELÇUKLU A., DOĞANAY M.

ECCMID 2016, 9 - 12 April 2016, (Summary Text)

26. Erciyes Üniversitesi Tıp Fakültesinde izlenen HIV olgularının değerlendirilmesi

DEMİRASLAN H., TOK T., DOĞANAY M.

İnfeksiyon Dünyası Çalıştayı, Ankara, Turkey, 24 - 27 March 2016, pp.108, (Full Text) Sustainable Development

27. Revelations from vaccination trials against anthrax in large animals improvement of diagnostic procedures and practical implications on the predicability of the outcome of an ongoing infection with B anthracis

KOEHLER S., NDUMNEGO O., BÜYÜK F., ÇELEBİ Ö., OTLU S., DOĞANAY M., et al.

The 7th International Conference on Bacillus anthracis, B.cereus and B.thuringiensis, New Delhi, India, 27 - 31 October 2015 Sustainable Development

28. Using a passive mouse protection model as substitute for direct lethal anthrax challenge in target animals

NDUMNEGO O., KOEHLER S., BÜYÜK F., ÇELEBİ Ö., OTLU S., DOĞANAY M., et al.

The 7th International Conference on Bacillus anthracis, B.cereus and B.thuringiensis (Bacillus ACT 2015), New Delhi, India, 27 - 31 October 2015

29. Current therapy in anthrax

DOĞANAY M.

The 7th Eurasia Congress of Infectious Diseases, Tiflis, Georgia, 30 September - 03 October 2015, (Summary Text)

30. Is it Different the Positivity Rate of Toxoplasma Gondii Antibody in HIV Patients than Population?

DEMİRASLAN H., EREN E., YAZAR S., ALP MEŞE E., DOĞANAY M.

The 7th Eurasia Congress of Infectious Diseases, Tiflis, Georgia, 30 September - 03 October 2015, pp.303, (Full Text) Sustainable Development

31. Is Piperacilline Tazobactam Effective as Carbapenem in Empirical Antimicrobial Treatment of Febrile Neutropenia

DEMİRASLAN H., METAN G., KAYNAR L., ALP MEŞE E., DOĞANAY M.

The 7th EURASIA CONGRESS OF INFECTIOUS DISEASES, 30 September - 03 October 2015, pp.150

32. A rare complication cutaneous anthrax caused by contaminated ointment A case report of anthrax sepsis

Uysal B., KILIÇ S., DOĞANAY M., AYAYDIN A., DEMİR T., ÇELEBİ B.

The 7th Eurasia Congress of Infectious Diseases, Tiflis, Georgia, 29 September - 03 October 2015

33. Injectional Severe Soft Tissue Infection; Is Non Steroid Anti- Inflammatory Drug Injection a Real Predisposition?

TÜRE Z., DEMİRASLAN H., ALP MEŞE E., ÇORUH A., DOĞANAY M.

The 7th Eurasia Congress of Infectious Diseases, Tiflis, Georgia, 30 September - 03 October 2015, vol.3, pp.81, (Full Text) Sustainable Development

34. Is piperacilline/tazobactam effective as carbapenem in empirical antimicrobial treatment of febrile neutropenia?

DEMİRASLAN H., Metan G., KAYNAR L., ALP MEŞE E., DOĞANAY M.

The 7th Eurasia Congress of Infectious Diseases, Tiflis, Georgia, 30 September - 03 October 2015, vol.42, pp.150, (Full Text) Sustainable Development

35. Are generic and original forms of piperacillin/tazobactam different in terms of false galactomannan test positivity?

DEMİRASLAN H., ATALAY M. A., EREN E., KAYNAR L., Demira K., KOÇ A. N., et al.

The 7th Eurasia Congress of Infectious Diseases (EACID), Tiflis, Georgia, 30 September - 03 October 2015, pp.97, (Summary Text)

36. Are Generic and Original Forms of Piperacillin TazobactamDifferent in Terms of False Galactomannan Test Positivity

DEMİRASLAN H., METAN G., KAYNAR L., ALP MEŞE E., DOĞANAY M.

The 7th EURASIA CONGRESS OF INFECTIOUS DISEASES, 30 September - 03 October 2015, pp.97

37. Are Generic and Original Forms of Piperacillin Tazobactam Different in Terms of False Galactomannan Test Positivity 7

DEMİRASLAN H., ATALAY M. A., EREN E., DEMİR K., KAYNAR L., KOÇ A. N., et al.

7. Eurasia Congress of Infectious Diseases (EACID), 30 September - 03 October 2015, pp.97

38. Human anthrax a summary of the different type of human infection and the prevalence of the disease in Turkey and the Caucuses

DOĞANAY M.

Anthrax Countermeasures: Vaccine and Environmental Decontamination, Tiflis, Georgia, 29 September 2015, (Summary Text) Sustainable Development

39. HIV Enfeksiyonunda Deri Bulguları

DOĞANAY M.

8. Dermatoloji Bahar Sempozyumu, Antalya, Turkey, 9 - 12 April 2015, (Summary Text) Sustainable Development

40. Steroid verilen farelerde karbapenem dirençli Klebsiella pneumoniae sepsisinde tigesiklin veya kolistin monoterapisine karşı tigesiklin kolistin kombinasyonu

DEMİRASLAN H., DİNÇ G., SALMAN S. A., ELMALI F., METAN G., DOĞANAY M.

Laboratuvar Hayvanları Bilimi 3. Ulusal Kongresi (Uluslararası katılımlı), Kayseri, Turkey, 26 - 28 September 2013, pp.84

41. Karbapenem dirençli Acinetobacter baumannii ile farelerde oluşturulan deneysel sepsisde doripenem ve kombinasyonları ile tedavi seçenekleri

DİNÇ G., DEMİRASLAN H., ELMALI F., SALMAN S. A., ALP E., DOĞANAY M.

Laboratuvar Hayvanları Bilimi 3. Ulusal Kongresi (Uluslararası katılımlı), Kayseri, Turkey, 26 - 28 September 2013, pp.82

42. TULAREMIA OUTBREAKS IN KAYSERİ, TURKEY: AN EVALUATION ON THR EFFECT OF CLİMATE CHANGE AND CLİMATE VARIABILITY ON TULAREMIA OUTBREAKS

BALCI E., BORLU A., ULU KILIÇ A., DEMİRASLAN H., ÖKSÜZKAYA A., DOĞANAY M.

INTERNATIONAL SYMPOSIUM ON FRANCISELLA TULARENSIS AND TULAREMIA, 19 - 22 June 2013, (Summary Text) Sustainable Development

43. Carbapenem resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice Tigecycline or colistin monotherapy versus tigecycline colistin combination

DEMİRASLAN H., DİNÇ G., SALMAN S. A., ELMALI F., METAN G., DOĞANAY M.

The 5th Eurasia Congress of Infectious Diseases, Tirane, Albania, 15 - 18 May 2013, pp.98

44. Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli

ULU KILIÇ A., UYSAL B., METAN G., DEMİRASLAN H., DOĞANAY M.

23rd European Congress of Clinical Microbiology an Infectious Diseases, Germany, 1 - 04 April 2013, no.2089, pp.170, (Full Text)

45. Farelerde Karbapenem Dirençli Acinetobacter baumannii Sepsisinde Tedavi Seçenekleri

DİNÇ G., DEMİRASLAN H., AHMED S. S., ELMALI F., ALP MEŞE E., DOĞANAY M.

EKMUD 2013 BİLİMSEL PLATFORMU, Antalya, Turkey, 1 - 04 March 2013, pp.138-139, (Full Text)

46. Yanık hastalarının hastane enfeksiyonları ve mortaliteleri için risk faktörleri: Bir Üniversite Hastanesinin 10 yıllık deneyimi.

ALP MEŞE E., ÇORUH A., GÜNAY G. K., YONTAR Y., DOĞANAY M.

l. Ulusal Çocuk Yanıkları Kongresi., Antalya, Turkey, 1 - 04 December 2011, pp.25-30, (Full Text)

47. Sepsis and meningitis due to Listeria monocytogenes

YILDIZ O., PERÇİN RENDERS D., AYGEN B., ALP MEŞE E., DOĞANAY M.

The versality of Listeria species FEMS Symposium, 30, İzmir, Turkey, Publication of The Turkish Microbiological Society, 3 - 05 January 2002

48. Nocardiosis in a teaching hospital in the Central Anatolia region treatment and outcome

YILDIZ O., ALP MEŞE E., TOKGÖZ B., Tucer B., AYGEN B., Sümerkan B., et al.

15th European Congress of Clinical Microbiology and Infectious Diseases, 1373, Copenhagen, Denmark, 2005, 7 - 09 January 2005

49. Investigation of the Hypothalamo pituitary adrenal Axis and Changes in the Size of Adrenal Glands in Acute Brucellosis

YILDIZ O., GÖKÇE C., ALP MEŞE E., DURAK A. C., AYGEN B., DOĞANAY M., et al.

12th International Congress of Endocrinology,156, Lisbon, Portugal, 2004., 1 - 03 January 2004

50. hematolojik maligniteli hastalardan izole edilen bakteriyel etkenler ve antibiyotik duyarlılıkları

ESER B., ÇETİN M., ÜNAL A., YILDIZ O., COŞKUN H. Ş., ER Ö., et al.

XIV Ulusal kanser kongresi, İstanbul, Turkey, 1 - 04 May 2001, (Summary Text)

51. Kanserli hastalarda bakteriyel ve fungal infeksiyon etkenleri

ESER B., ÇETİN M., ÜNAL A., ALTINBAŞ M., DOĞANAY M.

3. Febril nötropeni sempozyumu, Antalya, Turkey, 1 - 04 February 1999, pp.1, (Full Text) Sustainable Development

52. febril kanserli hastalarda saptanan infeksiyonlar ve mortalite

ESER B., ÇETİN M., ÜNAL A., ALTINBAŞ M., DOĞANAY M.

XXVI Ulusal hematoloji kongresi, Ankara, Turkey, 1 - 04 November 1998, pp.184, (Full Text) Sustainable Development

53. Enterokokların antibiyotik duyarlılıkları ve yüksek gentamisin direnci.

AYDIN N., KOÇ A. N., FAZLI Ş. A., DOĞANAY M.

7. Türk Antibiyotik ve Kemoterapi (ANKEM) Kongresi, 31 Mayıs-5 Haziran 1992, Kuşadası., Aydın, Turkey, 31 May - 06 June 1992, pp.159, (Full Text)

Books 13

Other Publications 2

1. Anthrax in Humans and Animals, Fourth edition

Turnbull P., Cosivi O., Ashford D., Beyer W., Cherkasskiy B., DOĞANAY M., et al.

Technical Report, pp.208, 2008

2. Guidelines for the Surveillance and Control of Anthrax in Human and Animals. 3rd edition.

Turnbull P. C., Cosivi O. .., Doğanay M., Hugh-Jones M., Joshi D., Lalitha M., et al.

Technical Report, pp.1-109, 1998

Metrics

Publication

247

Publication (WoS)

148

Publication (Scopus)

149

Citation (WoS)

1974

H-Index (WoS)

Citation (Scopus)

2610

H-Index (Scopus)

Citation (TrDizin)

H-Index (TrDizin)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works